| Risk | High |
|---|---|
| Min SIP Amount | ₹500 |
| Expense Ratio | 0.65% |
| NAV | ₹103.81 (27 Mar 2020) |
|---|---|
| Fund Started | 01 Jan 2013 |
| Fund Size | ₹6,213 Cr |
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| City Union Bank Ltd. | Financial | Equity | 2.7% |
| Cholamandalam Investment & Finance Co. Ltd. | Financial | Equity | 2.6% |
| Ipca Laboratories Ltd. | Healthcare | Equity | 2.5% |
| Bayer CropScience Ltd. | Healthcare | Equity | 2.5% |
| Shree Cement Ltd. | Construction | Equity | 2.5% |
| Abbott India Ltd. | Healthcare | Equity | 2.4% |
| The Ramco Cements Ltd. | Construction | Equity | 2.3% |
| Berger Paints India Ltd. | Chemicals | Equity | 2.2% |
| Manappuram Finance Ltd. | Financial | Equity | 2.1% |
| Atul Ltd. | Chemicals | Equity | 2.0% |
L&T Midcap Fund Direct Growth is a Equity Mutual Fund Scheme launched by L&T Mutual Fund. This scheme was introduced to investors on 01 Jan 2013. Soumendra Nath Lahiri, Vihang Naik is the Current Fund Manager of L&T Midcap Fund Direct Growth.The fund currently has an Asset Under Management(AUM) of ₹6,213 Cr and the Latest NAV as of 27 Mar 2020 is ₹103.81.
The L&T Midcap Fund Direct Growth is rated High risk. Minimum SIP Investment is 500. Minimum Lumpsum Investment is 5000. For units in excess of 10% of the investment, 1% will be charged for redemption within 1 year..